This website is for the U.S, for the other countries please refer to this link.

Events

Successful Webinar “Management of autonomic dysfunction” – July 2021

Events / By

Successful Webinar: Management of autonomic dysfunction: challenges & role of sudomotor testing With our special guests, on July 2021;     On July the 16th Impeto Medical had organized a webinar for health professionals on the Management of autonomic dysfunction. We were glad to welcome more than 50 attendees to this presentation with our special guests …

Successful Webinar “Management of autonomic dysfunction” – July 2021 Read More »

Successful Webinar “Early management of diabetes & microvascular complications” – April 2021

Events / By

Successful Webinar: Early Management of diabetes & microvascular complications. With our special guests, on April 2021;     On April 16 Impeto Medical had organized a webinar for health professionals on the Early management of diabetes & microvascular complications. We were glad to welcome more than 80 attendees to this presentation with our special guests Dr Prash Vas …

Successful Webinar “Early management of diabetes & microvascular complications” – April 2021 Read More »

Successful web conference 2020 on SUDOSCAN utility in diabetes

Events, News / By

SUCCESSFUL WEB CONFERENCE ON SUDOSCAN UTILITY IN DIABETES On July the 10th Impeto Medical has organized a web conference for diabetologists: Management of diabetic foot risk – a UK experience in quick screening and multifactorial interventions. During this web conference we had the pleasure to get an enriching feedback from Dr Dinesh SELVARAJAH (Senior Lecturer …

Successful web conference 2020 on SUDOSCAN utility in diabetes Read More »

EASD 2019 poster: diabetic foot risk detection with SUDOSCAN

Diabetes, Events, News, Scientific publications / By

EASD 2019 POSTER: DIABETIC FOOT RISK DETECTION A multi-center study (3 hospitals: Bichat, La Pitié Salpêtrière, Bégin) completed in France established the link between the grade of diabetic foot risk and the decrease of Electrochemical Skin Conductance (ESC) measured with SUDOSCAN. A poster has been presented at the European Association for the Study of Diabetes …

EASD 2019 poster: diabetic foot risk detection with SUDOSCAN Read More »

Promotional Communication. The medical devices SUDOSCAN is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12

Scroll to Top